Clinical trial

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

NCT05096338

Study summary

ClinicalTrials.gov

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Social Determinants of Health Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2021-10-27

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Cardiotoxicityunresolved

Cardiovascular Diseasesunresolved

Interventions

Social Determinants of HealthOTHER

Sponsors & collaborators

Abramson Cancer Center at Penn Medicinelead sponsor

American Heart Associationcollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05096338 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.